(VTR) Ventas - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US92276F1003
VTR: Senior Housing, Medical Buildings, Research Centers, Healthcare Facilities
Ventas, Inc. (NYSE: VTR) is a prominent S&P 500 real estate investment trust (REIT) specializing in healthcare and senior housing properties. With a diversified portfolio of approximately 1,350 assets across North America and the United Kingdom, the company is a key player in the longevity economy, catering to the growing aging population. Ventas operates over 800 senior housing communities, including assisted living, memory care, and independent living facilities, providing essential services that enhance residents quality of life. The portfolio also includes medical office buildings, outpatient facilities, and life science properties, further solidifying its position in the healthcare real estate sector. The company leverages its operational expertise, data-driven insights from its Ventas OI platform, and strong financial position to drive performance and deliver value to stakeholders. Ventass commitment to excellence, integrity, and innovation is reflected in its focus on creating environments that support longer, healthier, and happier lives.
As of the latest data, Ventas, Inc. (NYSE: VTR) trades at $67.93 with a market capitalization of $29.73 billion. The stock exhibits a moderate trading volume, averaging 3.76 million shares over the past 20 days. Its price-earnings ratio stands at 357.53, with a forward P/E of 185.19, indicating expectations for future earnings growth. The companys price-to-book ratio is 2.76, reflecting its asset valuation. Ventass trailing 12-month price-to-sales ratio is 6.08, and its return on equity (RoE) is 0.75. The stocks technical indicators show a 20-day simple moving average (SMA) of $67.28, 50-day SMA of $66.62, and 200-day SMA of $61.26, with an average true range (ATR) of 1.83.
Additional Sources for VTR Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
VTR Stock Overview
Market Cap in USD | 30,092m |
Sector | Real Estate |
Industry | REIT - Healthcare Facilities |
GiC Sub-Industry | Health Care REITs |
IPO / Inception | 1998-05-04 |
VTR Stock Ratings
Growth Rating | 69.2 |
Fundamental | 24.7 |
Dividend Rating | 48.1 |
Rel. Strength | 30.3 |
Analysts | 4.45/5 |
Fair Price Momentum | 72.41 USD |
Fair Price DCF | 39.50 USD |
VTR Dividends
Dividend Yield 12m | 2.91% |
Yield on Cost 5y | 7.30% |
Annual Growth 5y | -3.42% |
Payout Consistency | 97.2% |
VTR Growth Ratios
Growth Correlation 3m | 46.9% |
Growth Correlation 12m | 82.2% |
Growth Correlation 5y | 47.8% |
CAGR 5y | 21.16% |
CAGR/Max DD 5y | 0.51 |
Sharpe Ratio 12m | 1.83 |
Alpha | 46.88 |
Beta | 0.358 |
Volatility | 26.04% |
Current Volume | 7732.2k |
Average Volume 20d | 2744.7k |
As of May 02, 2025, the stock is trading at USD 65.54 with a total of 7,732,160 shares traded.
Over the past week, the price has changed by -4.20%, over one month by -5.38%, over three months by +7.56% and over the past year by +54.25%.
Neither. Based on ValueRay Fundamental Analyses, Ventas is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 24.66 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of VTR as of May 2025 is 72.41. This means that VTR is currently undervalued and has a potential upside of +10.48% (Margin of Safety).
Ventas has received a consensus analysts rating of 4.45. Therefor, it is recommend to buy VTR.
- Strong Buy: 12
- Buy: 5
- Hold: 3
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, VTR Ventas will be worth about 78.4 in May 2026. The stock is currently trading at 65.54. This means that the stock has a potential upside of +19.68%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 75.6 | 15.4% |
Analysts Target Price | 75.6 | 15.4% |
ValueRay Target Price | 78.4 | 19.7% |